From a biological perspective, should a causative relationship exist between BRCA pathogenic variants and endometrial cancer, it would be anticipated that the increased risk would be restricted to the serous-like histological subtype, including p53 mutant uterine carcinosaromas and mixed epithelial carcinomas [10]. This evidence concerns the gene TP53 and endometrial cancer.